[July 24, 2019: Minneapolis, MN] The U.S. Patent and Trademark Office (USPTO) has issued emerging medical device firm AdvancedCPR Solutions its fourth patent related to its ElevatedCPR method. The patent (U.S. Patent No. 10,350,137) is exclusively licensed to the company and covers methods for performing CPR while gradually elevating the patient’s head and heart. AdvancedCPR Solutions’ ElevatedCPR method could potentially improve outcomes after cardiac arrest, one of the leading causes of death worldwide, by lifting the head, heart, and thorax in a multi-level elevation, in a timed sequence, in conjunction with the best practice standards of resuscitation protocols.

“Our preclinical studies have demonstrated that the combination of multi-level elevated positioning with a timed sequence significantly enhances the outcomes of our ElevatedCPR method,” commented Philip Faris, AdvancedCPR Solutions’ CEO.  “This patent further protects the intellectual property we are developing from evidence-based research.”

The ElevatedCPR method is a technologically-advanced technique for performing device-assisted head up CPR that incorporates raising the head, heart, and thorax in a multi-level elevation, in a timed sequence, in conjunction with best practice resuscitation protocols.¹ This positioning allows the body to drain venous blood from the brain while CPR is being performed; and preclinical evidence shows a number of potential benefits associated with this method relative to intracranial pressure (ICP), cerebral perfusion pressure (CerPP) and coronary perfusion pressure (CorPP).^{2 3 4 5} The timing and elevation sequence for the ElevatedCPR method are scientifically based on preclinical studies which have shown a sequence that includes a two minute period of high quality CPR with active compression-decompression CPR or mechanical CPR and an impedance threshold device with the patient in the lowest elevation, followed by a slow progressive rise over two minutes to the highest elevation, significantly increases cerebral perfusion pressure to greater than 80 percent of normal and coronary perfusion pressure to greater than 70 percent of normal.^{. 2 3 6}

The company’s initial device, the EleGARD™ Patient Positioning System, precisely, rapidly, and consistently positions the patient for CPR and airway management and positions patients to support the use of the ElevatedCPR method in the pre-hospital and hospital settings. The EleGARD System has been adopted by several leading EMS agencies and will be widely available in 2019.

Founded in Minneapolis, Minnesota in 2015 by an experienced team that previously developed multiple novel resuscitation technologies currently in widespread clinical practice, AdvancedCPR Solutions is an early stage medical device firm focused on the development and commercialization of delivery mechanisms, methods and devices that enable the ElevatedCPR method.

###

1 Strobos,  Resuscitation 2018

2 Moore, et al., Circulation 2018

3 Rojas, et al., NAEMSP 2019 (Fig. 4)

4 Moore, et al., Resuscitation 2017

5 Moore, et al., Resuscitation 2018

6 Frascone, Gathering of Eagles 2019